Procurement Summary
Country : Mexico
Summary : Aa-050gyr003-e460-2021 Acquisition of Medication
Deadline : 22 Oct 2021
Other Information
Notice Type : Tender
TOT Ref.No.: 58827330
Document Ref. No. : 2349393
Financier : Self Financed
Purchaser Ownership : -
Tender Value : Refer Document
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
AA-050GYR003-E460-2021 Acquisition of Medicine
Ad description: AA-050GYR003-E460-2021 Acquisition of Medicine
010, 000.3624.00.00 Glucose 5% injectable solution Each 100 ml contain: anhydrous glucose or glucose 5 g or monohydrated glucose equivalent to 5.0 g of glucose. Container with 50 ml. Contains: glucose 2.5 g
010, 000.4036.00.00 Etofenamate - Injectable solution Each ampoule contains: Etofenamate 1 G. Container with a 2-ml ampoule.
010, 000.4242.00.00 ENOxAPARINA SOLUTION Each syringe contains: 20 mg sodium enoxaparin. Container with 2 syringes of 0.2 ml.
010, 000.4259.00.00 Ciprofloxacin Injectable solution Each 100 ml contains: lactate or ciprofloxacin hydrochloride equivalent to 200 mg of ciprofloxacin. Container with 100 ml.
010, 000.4260.00.00 Nistatin Oral suspension Each bottle with dust contains: Nistatin 2 400 000 IU. Container for 24 ml.
010, 000.5237.02.00 Interferon (beta) Solution Injectable Each jar press or pre-release syringe contains: interferon beta 1st 44 μg (12 million IU). Container with pre-filled syringe with 0.5 ml.
010, 000.5255.00.00 Trimethoprim and sulfametoxazole injectable solution each blister contie ...
Documents
Tender Notice